The IMPT serves as the ‘communications and information hub’ for the field of multipurpose prevention technologies (MPTs).

Our resource center features a searchable database, providing you access to global MPT research, technical webinars, trainee and career resources, advocacy tools, and more. Search our resources!

Resource Search

Search Results

TRIO Study Brief:  Long-Acting Injections for Women’s HIV Prevention in Sub-Saharan Africa: What End-Users Think

TRIO Study Brief: Long-Acting Injections for Women’s HIV Prevention in Sub-Saharan Africa: What End-Users Think

RTI International | Women’s Global Health Imperative; Impact Research and Development Organization, Kenya; Setshaba Research Centre, South Africa; The Initiative for MPTs (IMPT) February 2021
Market Access Framework for MPT Development

Market Access Framework for MPT Development

This framework is intended to serve as a resource to inform product development and investment decision-making that is focused specifically on market access components of MPT development and introduction—in other words, activities that are critical to ensuring that MPTs in development are not only efficacious in clinical trials, but also desired, acceptable, and accessible to […]

(IMPT) Initiative for Multipurpose Prevention Technologies Visit Technical Brief April 2019
Market Access Framework for Multipurpose Prevention Technology (MPT) Development and Introducion

Market Access Framework for Multipurpose Prevention Technology (MPT) Development and Introducion

Market Access Framework for Multipurpose Prevention Technology (MPT) Development and Introducion April 2019 click to view Technical Brief In this Technical Brief: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): MPTs Product Development Product Trials

Dellplain, L., Young Holt, B., Hemmerling, A., Romano, J., van der Straten, A., & Turpin, J. Visit Technical Brief April 2019
Building capacity for MPT product development

Building capacity for MPT product development

Building capacity for MPT product development July 2017 click to view Technical Brief In this Technical Brief: Health Risk(s): HIV STI / STD Unintended Pregnancy Topic(s): Policy Product Development Public-Private Partnerships Regulatory Issues Region(s): Global

Kilbourne-Brook, M. Visit Technical Brief July 2017
Building MPT acceptability during product development through consumer and health systems research

Building MPT acceptability during product development through consumer and health systems research

Building MPT acceptability during product development through consumer and health systems research July 2017 click to view Technical Brief In this Technical Brief: Health Risk(s): HIV STI / STD Unintended Pregnancy Topic(s): Product Development Product Introduction / Uptake Public-Private Partnerships Regulatory Issues Social/Behavioral Context Region(s): Global

Kilbourne-Brook, M. Visit Technical Brief July 2017
Strategic Evaluation Framework (SEF) for MPTs: Strategic Target Profile (STP) context summaries

Strategic Evaluation Framework (SEF) for MPTs: Strategic Target Profile (STP) context summaries

Strategic Evaluation Framework (SEF) for MPTs: Strategic Target Profile (STP) context summaries October 2017 Building upon the IMPT’s report: “Laying the Groundwork for a Strategic Evaluation Framework (SEF) for HIV Prevention and MPT Product Development,” the IMPT initiated the next steps to create a Strategic Target Profile (STP) for the dominant MPT product strategies in […]

October 2017
Join the MPT development collaboration

Join the MPT development collaboration

Join the MPT development collaboration November 2017 click to view Technical Brief In this Technical Brief: Topic(s): Product Development SRH Linkages Region(s): Global Working Group(s): (SAWG) Scientific Agenda Working Group

CAMI Health Visit Technical Brief November 2017
Traditional Socio-Behavioral Research and Human-Centered Design: Similarities, Unique Contributions and Synergies

Traditional Socio-Behavioral Research and Human-Centered Design: Similarities, Unique Contributions and Synergies

This report by Dr. Betsy Tolley (FHI 360) presents learnings and reflections on traditional socio-behavioral research (SBR) and human-centered design (HCD) as applied to the global health context – specifically in biomedical prevention for sexual and reproductive health. In comparing these methodologies and examining their strengths and shortcomings, we can identify potential synergies to further […]

Tolley, E.B., FHI 360 December 2017
Status of Modelling Efforts in the Field of Multipurpose Prevention Technologies: Summary Report

Status of Modelling Efforts in the Field of Multipurpose Prevention Technologies: Summary Report

Status of Modelling Efforts in the Field of Multipurpose Prevention Technologies: Summary Report February 2017 click to view Technical Brief In this Technical Brief: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): ARVs IVR (Intravaginal Rings) MPTs Vaginal Cream/Gel Vaginal Film Topic(s): Collective Impact Education MPTs Risk

Dellplain, L., Polis, C., & Royal, D. Visit Technical Brief February 2017
MPTs: Building momentum through awareness-raising and advocacy

MPTs: Building momentum through awareness-raising and advocacy

MPTs: Building momentum through awareness-raising and advocacy July 2017 click to view Technical Brief In this Technical Brief: Health Risk(s): HIV STI / STD Unintended Pregnancy Topic(s): Advocacy Education Product Development Social/Behavioral Context Region(s): Global

Kilbourne-Brook, M. Visit Technical Brief July 2017
Clinical Trial Evaluation Workshop for MPTs: Strategic Steps to Ensure Success

Clinical Trial Evaluation Workshop for MPTs: Strategic Steps to Ensure Success

Clinical Trial Evaluation Workshop for MPTs: Strategic Steps to Ensure Success 13-14 September 2016 Washington, DC, USA click to view Technical Brief In this Technical Brief: Topic(s): Product Trials

Visit Technical Brief September 2016
Laying the Groundwork for a Strategic Evaluation Framework (SEF) for HIV Prevention and MPT Product Development

Laying the Groundwork for a Strategic Evaluation Framework (SEF) for HIV Prevention and MPT Product Development

Laying the Groundwork for a Strategic Evaluation Framework (SEF) for HIV Prevention and MPT Product Development 30 September 2016 This report outlines the methodology and results of an IMPT Secretariat project that was funded by USAID’s Office of HIV/AIDS, the objective of which was to create the foundation for a Strategic Evaluation Framework (SEF) for […]

Dellplain, L. & Thomas, V. September 2016
2015 IMPT Priority Issues Identification Exercise

2015 IMPT Priority Issues Identification Exercise

2015 IMPT Priority Issues Identification Exercise 2015 click to view Technical Brief In this Technical Brief: Health Risk(s): HIV STI / STD Unintended Pregnancy Topic(s): Education Funding MPTs Region(s): Global

CAMI Health Visit Technical Brief January 2015
MPT Product Prioritization and Gap Analysis: 2014 Summary

MPT Product Prioritization and Gap Analysis: 2014 Summary

MPT Product Prioritization and Gap Analysis: 2014 Summary 2014 click to view Technical Brief In this Technical Brief: Health Risk(s): HIV HPV HSV STI / STD Unintended Pregnancy Product Type(s): ARVs Hormonal Contraceptives IVR (Intravaginal Rings) Vaginal Film Region(s): Africa China Europe India United States Working Group(s): (SAWG) Scientific Agenda Working Group (SACC) Supporting Agency […]

Drug Interactions between Hormonal Contraceptive Methods and Anti-Retroviral Medications Used to Treat HIV

Drug Interactions between Hormonal Contraceptive Methods and Anti-Retroviral Medications Used to Treat HIV

Drug Interactions between Hormonal Contraceptive Methods and Anti-Retroviral Medications Used to Treat HIV October 2014 click to view Technical Brief In this Technical Brief: Health Risk(s): HIV Unintended Pregnancy Product Type(s): ARVs Hormonal Contraceptives Topic(s): Drug Interactions Risk Region(s): Global

USAID Visit Technical Brief October 2014
Guidance for Industry – Vaginal Microbicides: Development for the Prevention of HIV Infection

Guidance for Industry – Vaginal Microbicides: Development for the Prevention of HIV Infection

Guidance for Industry – Vaginal Microbicides: Development for the Prevention of HIV Infection November 2014 click to view Technical Brief In this Technical Brief: Health Risk(s): HIV Product Type(s): ARVs Microbicides Topic(s): Product Development Regulatory Issues Region(s): United States

U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER). Visit Technical Brief November 2014
MPT Dosage-Form Specific Target Product Profiles (TPPs)

MPT Dosage-Form Specific Target Product Profiles (TPPs)

MPT Dosage-Form Specific Target Product Profiles (TPPs) 2014 In 2012, Initiative for Multipurpose Prevention Technologies (IMPT) managed an exercise to define general target attributes for MPT products. While prioritizing specific MPT product dosage forms (i.e., long acting injectables, intravaginal rings, and on-demand products), it became clear that it was necessary to move beyond a listing […]

CAMI Health January 2014